Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Martin

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Orthopedics|November 10, 2007
Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapyVeena Venugopalan, Craig A Martin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndromeCraig A Martin, Sara Roberts, Richard N Greenberg
Pharmacotherapy|October 1, 2014
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistanceJeffrey M Rybak, Kayleigh Marx, Craig A Martin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 22, 2011
A Web-based experiential rotation platformAaron M Cook, Dan A Lewis, Craig A Martin
The Annals of Pharmacotherapy|April 29, 2004
Rash associated with piperacillin/tazobactam administration in infectious mononucleosisAimée C LeClaire, Craig A Martin, Ardis D Hoven
Pediatric Neurosurgery|June 9, 2005
Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infectionAaron M Cook, Christian N Ramsey, Craig A Martin, et al.
Journal of Chemotherapy (Florence, Italy)|July 5, 2016
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilliBenjamin J Ereshefsky, Majdi N Al-Hasan, Yevgeniya Gokun, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 5, 2011
Moving antimicrobial stewardship from restriction to facilitationCraig A Martin, John A Armitstead, Ryan P Mynatt, et al.
Pharmacotherapy|March 16, 2005
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureusShellee A Grim, Robert P Rapp, Craig A Martin, et al.
Orthopedics|June 22, 2006
Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitisMeredith B Toma, Kelly M Smith, Craig A Martin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Orthopedics|November 10, 2007
Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapyVeena Venugopalan, Craig A Martin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndromeCraig A Martin, Sara Roberts, Richard N Greenberg
Pharmacotherapy|October 1, 2014
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistanceJeffrey M Rybak, Kayleigh Marx, Craig A Martin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 22, 2011
A Web-based experiential rotation platformAaron M Cook, Dan A Lewis, Craig A Martin
The Annals of Pharmacotherapy|April 29, 2004
Rash associated with piperacillin/tazobactam administration in infectious mononucleosisAimée C LeClaire, Craig A Martin, Ardis D Hoven
Pediatric Neurosurgery|June 9, 2005
Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infectionAaron M Cook, Christian N Ramsey, Craig A Martin, et al.
Journal of Chemotherapy (Florence, Italy)|July 5, 2016
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilliBenjamin J Ereshefsky, Majdi N Al-Hasan, Yevgeniya Gokun, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 5, 2011
Moving antimicrobial stewardship from restriction to facilitationCraig A Martin, John A Armitstead, Ryan P Mynatt, et al.
Pharmacotherapy|March 16, 2005
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureusShellee A Grim, Robert P Rapp, Craig A Martin, et al.
Orthopedics|June 22, 2006
Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitisMeredith B Toma, Kelly M Smith, Craig A Martin, et al.
Pageof 3